Charité – Universitätsmedizin Berlin at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Charité – Universitätsmedizin Berlin brings 15 presentations to ESGCT 2026 in Hamburg. Its work centres on engineered T cells and regulatory T cells for cancer and transplantation, and on manufacturing them without viral vectors. One strand uses base editing to make those cells resistant to the immunosuppressive drugs patients take alongside the therapy.
| Organization | ESGCT 2026 Attendance |
|---|---|
Charité – Universitätsmedizin Berlin Berlin, Germany | |
Berlin's university hospital and medical faculty, with research and trials in cell and gene therapy, including engineered T cells. | Talk Tue Oct 27 6:00pm–7:30pm Adenine base editing of FKBP12 and NR3C1 creates tacrolimus- and glucocorticoid-resistant T cells and Tregs for transplant immunotherapy Gene and epigenome editingCell therapies and CAR-T Poster Wed Oct 28 1:30pm–3:30pm Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation Poster Wed Oct 28 1:30pm–3:30pm Computational structure prediction guides rational design of enhanced CARs targeting a membrane-proximal epitope of IgA1 Poster Wed Oct 28 1:30pm–3:30pm Lipid nanoparticle-mediated multiplex engineering for virus free and scalable ex vivo manufacturing of T cells Poster Wed Oct 28 1:30pm–3:30pm Modulated CD3z signaling enhances persistence and tumor control of non-viral TRAC-integrated FcRL5-CAR T cells for MM and CLL Poster Wed Oct 28 1:30pm–3:30pm Multidimensional Evaluation of TCE-09B, a Novel Serum-Free Medium for Non-Viral CAR-T Cell Manufacturing Poster Wed Oct 28 1:30pm–3:30pm Scalable GMP-compliant manufacturing of T-cell products using semi-closed and automated bioreactors Poster Wed Oct 28 1:30pm–3:30pm Toward Off-the-Shelf Treg Therapies: Integrating Immunogenicity Prediction and Functional Validation Platforms Cell therapies and CAR-T Poster Thu Oct 29 2:00pm–4:00pm Combinatorial CD4+ and CD8+ TCR-T Cell therapy enhances anti-tumor responses to mutant p53 Poster Thu Oct 29 2:00pm–4:00pm Development and Comprehensive Characterization of GMP-Compliant Effector T Cells for Advanced Adoptive T-Cell Therapy Poster Thu Oct 29 2:00pm–4:00pm Establishment of a PTLD infection model and functional analysis of EBV-specific T-cells Poster Thu Oct 29 2:00pm–4:00pm Multiplex gene-edited "off the shelf" CAR T cells resist allo-rejection and glucocorticoid co-treatment Poster Thu Oct 29 2:00pm–4:00pm Optimizing Functional Assays for the Evaluation of regulatory T Cell product candidates Cell therapies and CAR-T Poster Thu Oct 29 2:00pm–4:00pm Pooled knock-in screening reveals principles for improved CAR T-cell design Talk Fri Oct 30 12:30pm–1:00pm One-pot PASTA: A CRISPR-integrase platform for efficient, site-specific integration of large transgenes in primary human T cells Gene and epigenome editingCell therapies and CAR-T |
Instantly find 20 buyers from Charité – Universitätsmedizin Berlin
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction